Filter Results :

Your search for Cancer returned 1081 reports

Sort by


Global & USA Cancer Immunotherapy Market Analysis To 2020

01 Apr 2015  |  Published by:  Kelly Scientific Publications
GLOBAL & USA CANCER IMMUNOTHERAPY MARKET ANALYSIS TO 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells, Checkpoint Inhibitors, Adopted Cell...

$ 2,800.00

Read More

Global Small Cell Lung Cancer Therapeutics Market 2015-2019

18 Mar 2015  |  Published by:  Technavio
About Small Cell Lung Cancer Cancer occurs when, after cell transformation, normal cells grow and multiply without control. Lung cancer is a common cause of mortality and morbidity in developed and developing countries. Smoking is considered to be the major cause of small cell lung cancer, though it...

$ 3,000.00

Read More

HER-2 Positive Breast Cancer Market in the US 2015-2019

18 Mar 2015  |  Published by:  Technavio
About HER-2 Positive Breast Cancer Breast cancer is characterized by uncontrolled growth of cancerous cells in the breast. It occurs in both males and females, however, the incidence of breast cancer in males is rare. Histologically, breast cancer can be classified into ductal carcinoma, lobular car...

$ 3,000.00

Read More

Bladder Cancer Partnering 2010-2015

05 Mar 2015  |  Published by:  CurrentPartnering
The Bladder Cancer Partnering 2010-2015 report provides understanding and access to the bladder cancer partnering deals and agreements entered into by the worlds leading healthcare companies. -Trends in bladder cancer partnering deals-Top bladder cancer deals by value-Deals listed by company A-...

$ 795.00

Read More

Global HER-2 Positive Breast Cancer Market 2015-2019

04 Mar 2015  |  Published by:  Technavio
Breast cancer is characterized by uncontrolled growth of cancerous cells in the breast. It occurs in both males and females, however, the incidence of breast cancer in males is rare. Histologically, breast cancer can be classified into ductal carcinoma, lobular carcinoma, nipple cancer, and other...

$ 3,000.00

Read More

Cervical Cancer Partnering 2010-2015

03 Mar 2015  |  Published by:  CurrentPartnering
The Cervical Cancer Partnering 2010-2015 report provides understanding and access to the cervical cancer partnering deals and agreements entered into by the worlds leading healthcare companies. -Trends in cervical cancer partnering deals-Top cervical cancer deals by value-Deals listed by compan...

$ 795.00

Read More

Breast Cancer Partnering 2010-2015

02 Mar 2015  |  Published by:  CurrentPartnering
...

$ 1,795.00

Read More

Colorectal Cancer Partnering 2010-2015

01 Mar 2015  |  Published by:  CurrentPartnering
The Colorectal Cancer Partnering 2010-2015 report provides understanding and access to the colorectal cancer partnering deals and agreements entered into by the worlds leading healthcare companies. -Trends in colorectal cancer partnering deals-Top colorectal cancer deals by value-Deals listed b...

$ 995.00

Read More

Non-Small Cell Lung Cancer Partnering 2010-2015

01 Mar 2015  |  Published by:  CurrentPartnering
The Non-Small Cell Lung Cancer Partnering 2010-2015 report provides understanding and access to the non-small cell lung cancer partnering deals and agreements entered into by the worlds leading healthcare companies. -Trends in non-small cell lung cancer partnering deals-Top non-small cell lung ...

$ 795.00

Read More

Brain Cancer Partnering 2010-2015

01 Mar 2015  |  Published by:  CurrentPartnering
The Brain Cancer Partnering 2010-2015 report provides understanding and access to the brain cancer partnering deals and agreements entered into by the worlds leading healthcare companies. -Trends in brain cancer partnering deals-Top brain cancer deals by value-Deals listed by company A-Z, indus...

$ 795.00

Read More

Gastric Cancer Partnering 2010-2015

01 Mar 2015  |  Published by:  CurrentPartnering
The Gastric Cancer Partnering 2010-2015 report provides understanding and access to the gastric cancer partnering deals and agreements entered into by the worlds leading healthcare companies. -Trends in gastric cancer partnering deals-Top gastric cancer deals by value-Deals listed by company A-...

$ 795.00

Read More

Ovarian Cancer: KOL Insight

27 Feb 2015  |  Published by:  FirstWord
Ovarian Cancer: KOL Insight, A new era of targeted therapy provides leading clinician insights on new ovarian cancer (OC) drugs at a time of significant change in the therapy landscape. Why This Report is Essential A number of targeted therapies including VEGF, angiopoietin, PARP and MEK ...

$ 7,495.00

Read More

Cancer Nanomedicine Market & Pipeline Insight 2015

25 Feb 2015  |  Published by:  KuicK Research
During the last decade, there has been significant impact of the emergence of nanotechnology on clinical therapeutics. The pharmaceutical industry has witnessed advances in biocompatible nanoscale drug carriers in the form of liposomes and polymeric nanparticles which have the potential to del...

$ 2,000.00

Read More

Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015

24 Feb 2015  |  Published by:  Global Markets Direct
Summary‘Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015’, provides an overview of the Transitional Cell Cancer (Urothelial Cell Cancer)’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Transitional Cell Cancer (Urot...

$ 2,000.00

Read More

Global Lung Cancer Vaccine Market & Pipeline Insight 2015

24 Feb 2015  |  Published by:  KuicK Research
Lung cancer incidences are rapidly increasing and various therapeutics have been introduced in global market to provide better care to patients. Surgery and radiation therapy are not preferred for lung cancer treatment due to which they have small global market size. Chemotherapeutics and targ...

$ 1,200.00

Read More
Total 1081 records.